These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
406 related articles for article (PubMed ID: 12219087)
1. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nakae J; Biggs WH; Kitamura T; Cavenee WK; Wright CV; Arden KC; Accili D Nat Genet; 2002 Oct; 32(2):245-53. PubMed ID: 12219087 [TBL] [Abstract][Full Text] [Related]
2. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. Kitamura T; Nakae J; Kitamura Y; Kido Y; Biggs WH; Wright CV; White MF; Arden KC; Accili D J Clin Invest; 2002 Dec; 110(12):1839-47. PubMed ID: 12488434 [TBL] [Abstract][Full Text] [Related]
3. FoxO1 Plays an Important Role in Regulating β-Cell Compensation for Insulin Resistance in Male Mice. Zhang T; Kim DH; Xiao X; Lee S; Gong Z; Muzumdar R; Calabuig-Navarro V; Yamauchi J; Harashima H; Wang R; Bottino R; Alvarez-Perez JC; Garcia-Ocaña A; Gittes G; Dong HH Endocrinology; 2016 Mar; 157(3):1055-70. PubMed ID: 26727107 [TBL] [Abstract][Full Text] [Related]
4. Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism. Qu S; Altomonte J; Perdomo G; He J; Fan Y; Kamagate A; Meseck M; Dong HH Endocrinology; 2006 Dec; 147(12):5641-52. PubMed ID: 16997836 [TBL] [Abstract][Full Text] [Related]
5. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Matsumoto M; Pocai A; Rossetti L; Depinho RA; Accili D Cell Metab; 2007 Sep; 6(3):208-16. PubMed ID: 17767907 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. Altomonte J; Richter A; Harbaran S; Suriawinata J; Nakae J; Thung SN; Meseck M; Accili D; Dong H Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E718-28. PubMed ID: 12783775 [TBL] [Abstract][Full Text] [Related]
8. Lilly lecture 2003: the struggle for mastery in insulin action: from triumvirate to republic. Accili D Diabetes; 2004 Jul; 53(7):1633-42. PubMed ID: 15220184 [TBL] [Abstract][Full Text] [Related]
9. Depletion of hepatic forkhead box O1 does not affect cholelithiasis in male and female mice. Feng X; Zhu C; Lee S; Gao J; Zhu P; Yamauchi J; Pan C; Singh S; Qu S; Miller R; Monga SP; Peng Y; Dong HH J Biol Chem; 2020 May; 295(20):7003-7017. PubMed ID: 32273342 [TBL] [Abstract][Full Text] [Related]
10. Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. Samuel VT; Choi CS; Phillips TG; Romanelli AJ; Geisler JG; Bhanot S; McKay R; Monia B; Shutter JR; Lindberg RA; Shulman GI; Veniant MM Diabetes; 2006 Jul; 55(7):2042-50. PubMed ID: 16804074 [TBL] [Abstract][Full Text] [Related]
11. Legacy Effect of Foxo1 in Pancreatic Endocrine Progenitors on Adult β-Cell Mass and Function. Talchai SC; Accili D Diabetes; 2015 Aug; 64(8):2868-79. PubMed ID: 25784544 [TBL] [Abstract][Full Text] [Related]
12. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. Matsumoto M; Han S; Kitamura T; Accili D J Clin Invest; 2006 Sep; 116(9):2464-72. PubMed ID: 16906224 [TBL] [Abstract][Full Text] [Related]
13. Dissociation of the glucose and lipid regulatory functions of FoxO1 by targeted knockin of acetylation-defective alleles in mice. Banks AS; Kim-Muller JY; Mastracci TL; Kofler NM; Qiang L; Haeusler RA; Jurczak MJ; Laznik D; Heinrich G; Samuel VT; Shulman GI; Papaioannou VE; Accili D Cell Metab; 2011 Nov; 14(5):587-97. PubMed ID: 22055502 [TBL] [Abstract][Full Text] [Related]
15. An insulin-independent mechanism for transcriptional regulation of Foxo1 in type 2 diabetic mice. Ge W; Zhao Y; Yang Y; Ding Z; Xu X; Weng D; Wang S; Cheng R; Zhang J J Biol Chem; 2021 Jul; 297(1):100846. PubMed ID: 34058194 [TBL] [Abstract][Full Text] [Related]
16. Role of the forkhead protein FoxO1 in beta cell compensation to insulin resistance. Okamoto H; Hribal ML; Lin HV; Bennett WR; Ward A; Accili D J Clin Invest; 2006 Mar; 116(3):775-82. PubMed ID: 16485043 [TBL] [Abstract][Full Text] [Related]
17. Activation of Foxo1 by insulin resistance promotes cardiac dysfunction and β-myosin heavy chain gene expression. Qi Y; Zhu Q; Zhang K; Thomas C; Wu Y; Kumar R; Baker KM; Xu Z; Chen S; Guo S Circ Heart Fail; 2015 Jan; 8(1):198-208. PubMed ID: 25477432 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of FOXO1 transcription factor in primary human adipocytes mimics the insulin-resistant state of type 2 diabetes. Rajan MR; Nyman E; Brännmark C; Olofsson CS; Strålfors P Biochem J; 2018 May; 475(10):1807-1820. PubMed ID: 29724916 [TBL] [Abstract][Full Text] [Related]
19. Effect of forkhead box O1 (FOXO1) on beta cell development in the human fetal pancreas. Al-Masri M; Krishnamurthy M; Li J; Fellows GF; Dong HH; Goodyer CG; Wang R Diabetologia; 2010 Apr; 53(4):699-711. PubMed ID: 20033803 [TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor γ (PPARγ) and its target genes are downstream effectors of FoxO1 protein in islet β-cells: mechanism of β-cell compensation and failure. Gupta D; Leahy AA; Monga N; Peshavaria M; Jetton TL; Leahy JL J Biol Chem; 2013 Aug; 288(35):25440-25449. PubMed ID: 23788637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]